Efficacy of proplanorol for infantile hemangioma

Efficacy of proplanorol for infantile hemangioma - Proplanorol for infantile hemangioma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020220

Enrollment

Registered

2016-01-15

Start date

2016-01-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infantile Hemangioma

Interventions

oral administration of proplanorol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)patients with Infantile Hemangioma in Tohoku University Hospital Department of Pediatrics (2)Infant with huge Hemangioma that on the face and neck, near the eyelid (3)Patients without any organ failure (4) Written consent is necessary.

Exclusion criteria

Exclusion criteria: Patients with .. cardiogenic shock sinus bradycardia long QT syndrome hypotension atrioventricular block heart failure bronchial asthma infectious diseases hypersensitivity to propranolol Kasabach-Merritt syndrome PHACE syndrome

Design outcomes

Primary

Measure	Time frame
Response rate at 12 weeks	—

Countries

Japan

Contacts

Public ContactTakeshi Rikiishi

Tohoku University Hospital Department of Pediatrics

trikiishi@med.tohoku.ac.jp022-717-7287

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026